Search Results

Quinidine.

Subjects: QUINIDINE; DRUGS; WORLD Health Organization. Expert Committee

• Source: WHO Technical Report Series; 2005, Issue 933, p23-23, 1/3p

Record details

Tenders Info Reports 03-11-2020: China.

Subjects: LETTING of contracts; QUINIDINE; DRUG pricesCHINA

• Source: Tenders Info Reports; 3/11/2020, pN.PAG-N.PAG, 1p

Record details

General News Update.

Subjects: PHARMACEUTICAL industryUNITED StatesELI Lilly & Co.; PALADIN Labs Inc.; NUVO Pharmaceuticals Inc.

• Source: PharmaWatch: CNS; Jul2008, Vol. 7 Issue 7, p15-16, 2p

Record details

R&D Update.

Subjects: PHARMACEUTICAL industry; CLINICAL trials; DRUG developmentWYETH Pharmaceuticals Inc.; PROGENICS Pharmaceuticals Inc.; AVANIR Pharmaceuticals Inc.

• Source: PharmaWatch: CNS; Jul2008, Vol. 7 Issue 7, p14-15, 2p

Record details

Other Psychiatry News.

Subjects: PHARMACEUTICAL industry; PSEUDOBULBAR paralysis; MENTAL healthAVANIR Pharmaceuticals Inc.

• Source: PharmaWatch: CNS; Nov2007, Vol. 6 Issue 11, p8-9, 2p

Record details

Hearing Loss.

Subjects: TREATMENT of deafness; DEAFNESS prevention; HEARING

• Source: Hearing Loss: A Guide to Prevention & Treatment; 2016, p1-48, 51p

Record details

Schizophrenia Update.

Subjects: SCHIZOPHRENIA; PHARMACEUTICAL industry; BIPOLAR disorderALEXZA Pharmaceuticals Inc.; STACCATO (Company)

• Source: PharmaWatch: CNS; Nov2007, Vol. 6 Issue 11, p8-8, 1/2p

Record details

Using Literal Text From the Death Certificate to Enhance Mortality Statistics: Characterizing Drug Involvement in Deaths.

• Authors : Trinidad, James P.; Warner, Margaret; Bastian, Brigham A.

• Source: National Vital Statistics Reports; 12/20/2016, Vol. 65 Issue 9, preceding p1-147, 162p

Record details

AAN 2011: recent FDA approvals for niche indications provide a positive tone.

Subjects: NEUROPATHY; DRUG approval; THERAPEUTICSHONOLULU (Hawaii); HAWAIIUNITED States. Food & Drug Administration; AVANIR Pharmaceuticals Inc.; DEPOMED Inc.

• Source: PharmaWatch: CNS; Jun2011, Vol. 10 Issue 6, p13-15, 3p

Record details

AAN 2011: Gilenya raises the bar for prospective MS market entrants.

Subjects: MULTIPLE sclerosis treatment; DRUG efficacy; NEUROLOGY conferencesHONOLULU (Hawaii); HAWAIIGENZYME Corp.; SANOFI-Aventis SA; EISAI Co. Ltd.

• Source: PharmaWatch: CNS; Jun2011, Vol. 10 Issue 6, p11-13, 3p

Record details